Newsroom

Light microscopy of red blood cells, some are infected with Plasmodium

News

It has long been known that bacterial pathogens are becoming increasingly resistant to antibiotics. However, common medications are also becoming less effective against malaria, a tropical disease caused by a parasite. To counteract this development, a research team at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), in collaboration with the Swiss Tropical and Public Health Institute (Swiss TPH), has now developed a new drug candidate that can kill the malaria pathogen even when existing drugs are no longer effective. The team has now published its findings in the journal Angewandte Chemie.

22.10.2025

HIPS

Fluorescence microscopy of cells in magenta and blue

News

Natural products derived from microorganisms are a promising source of new active ingredients, but are often produced only in very small quantities. A research team from the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) led by Tobias Gulder has now succeeded in establishing a chemo-enzymatic platform for the production of furanolides – a class of natural products with a broad spectrum of activity. This strategy not only allows furanolides to be produced cost-effectively, but also enables structural modifications to be made. The newly generated molecules are capable of effectively combating both bacterial pathogens and cancer cells. The team has now published its findings in the Journal of the American Chemical Society.

20.10.2025

HIPS

Two speakers in front of a presentation on a screen

News

On 9 and 10 October 2025, the One Lab Retreat of the Helmholtz Centre for Infection Research (HZI) took place at the Wyndham Hannover Atrium. Researchers, managers and task force representatives from all HZI sites came together to present current scientific results, discuss interdisciplinary topics and further develop strategic cooperation.

13.10.2025

News

Professor Rolf Müller, Scientific Director of the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and Professor of Pharmaceutical Biology at Saarland University, has been awarded the Mannich Medal by the German Pharmaceutical Society (DPhG). Awarded in honour of the German chemist Carl Mannich, the medal is the DPhG's highest scientific accolade and is presented annually for “outstanding achievements in the field of pharmaceutical sciences”. The medal was presented at the DPhG's annual conference in Freiburg on October 1, 2025. HIPS is a site of the Helmholtz Centre for Infection Research (HZI) in collaboration with Saarland University.

07.10.2025

HIPS

News

Influenza is much more than just a nasty cold – it is one of the most dangerous infectious diseases worldwide, claiming around half a million lives every year. What makes it particularly insidious is that flu viruses are contagious even before the first symptoms appear. Despite this threat, the diagnostic options available to date are far from ideal. They are often expensive, complicated to use and simply unavailable in many poorer regions of the world. A research team led by Professor Lorenz Meinel from the University of Würzburg in cooperation with researchers from the Helmholtz Centre for Infection Research has developed the technology behind a new self-test for influenza, recently published in ACS Central Science.

02.10.2025

HZI Campus

News

Five young scientists were honored in Innsbruck on Wednesday for their internationally outstanding work: The Life Sciences Research Awards Austria 2025 of the Austrian Society for Molecular Biosciences and Biotechnology (ÖGMBT) went to Victoria Deneke (IMP Vienna), Rémi Hocq (TU Vienna) and Eugenia Pankevich (CeMM). The Life Sciences PhD Awards Austria 2025 went to Yannick Weyer (Medical University of Innsbruck) and Max Kellner (formerly IMBA, since 2025 Helmholtz Centre for Infection Research (HZI)).

25.09.2025

HZI Campus

HZI in the media

their biological activity. HIPS is a site of the Helmholtz Center for Infection Research (HZI) in collaboration with Saarland University.

20.10.2025

Phys.org

... die Abteilung „Experimentelle Immunologie“ am Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig, lehrt als Professor an ...

17.10.2025

Deutsches Ärzteblatt

Einrichtungen als nationale assoziierte Partner: das Helmholtz-Zentrum für Infektionsforschung Braunschweig, die Universität Bayreuth, das

17.10.2025

AlphaGalileo

... diesem Ergebnis kommt ein Forschungsteam des Helmholtz-Zentrums für Infektionsforschung (HZI) in Zusammenarbeit mit der ...

14.10.2025

Deutsches Ärzteblatt

Individualisierte Infektionsmedizin, einer gemeinsamen Einrichtung des Helmholtz-Zentrums für Infektionsforschung und der MHH. Bis zuletzt

13.10.2025

Springer

Ein Grippe-Test könnte in Zukunft womöglich sehr schnell gehen: einfach ein Kaugummi kauen. Ein deutsches ...

09.10.2025

Apotheken Umschau

... am 1. Oktober 2025. Das HIPS ist ein Standort des Helmholtz-Zentrums für Infektionsforschung (HZI) in ...

07.10.2025

juraforum.de

... „Epidemiologie und Ökologie antimikrobieller Resistenz“ am HZI-Standort Helmholtz-Institut für One Health (HIOH), am Projekt ...

06.10.2025

Bochumer-Zeitung

” says Mark Brönstrup, a professor at both the Helmholtz Center for Infection Research and Leibniz University Hannover, who wasn’t involved

04.10.2025

MIT CSAIL

... Hannover (MHH) und Klinischer Direktor des Helmholtz-Zentrums für Infektionsforschung (HZI). Auch an der Gründung des ...

03.10.2025

Deutsches Ärzteblatt

... des Sensormoleküls

Prof. Carlos A. Guzmán (Helmholtz-Zentrum für Infektionsforschung, Braunschweig) mit den Teams um Dr. ...

02.10.2025

Medizin Aspekte

... ” Seit Mai 2025 im Humanprogramm des Helmholtz-Zentrums für Infektionsforschung (HZI), Dr. Max Kellner-Leiter der jungen ...

25.09.2025

Die heutigen Nachrichten

Register now for the HZI-Newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.